BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12167432)

  • 1. Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue.
    Goto H; Kawano K; Kobayashi I; Sakai H; Yanagisawa S
    Oral Oncol; 2002 Sep; 38(6):549-56. PubMed ID: 12167432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
    Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
    Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
    Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
    Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
    Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3β signaling.
    Liu W; Hu M; Wang Y; Sun B; Guo Y; Xu Z; Li J; Han B
    Oncol Rep; 2015 Mar; 33(3):1049-56. PubMed ID: 25591548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F; Sasaguri T
    Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer.
    Cho YJ; Kim JH; Yoon J; Cho SJ; Ko YS; Park JW; Lee HS; Lee HE; Kim WH; Lee BL
    BMC Gastroenterol; 2010 Aug; 10():91. PubMed ID: 20704706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β.
    Chen X; Zhang L; Zheng S; Zhang T; Li M; Zhang X; Zeng Z; McCrae MA; Zhao J; Zhuang H; Lu F
    Cancer Prev Res (Phila); 2015 May; 8(5):455-63. PubMed ID: 25712050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
    Singh LP; Jiang Y; Cheng DW
    Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
    Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
    J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma.
    Mineta H; Miura K; Takebayashi S; Ueda Y; Misawa K; Harada H; Wennerberg J; Dictor M
    Oral Oncol; 2000 Mar; 36(2):194-8. PubMed ID: 10745172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high expression of TC1 (C8orf4) was correlated with the expression of β-catenin and cyclin D1 and the progression of squamous cell carcinomas of the tongue.
    Zhang P; Cao HY; Bai LL; Li WN; Wang Y; Chen SY; Zhang L; Yang LH; Xu HT; Wang EH
    Tumour Biol; 2015 Sep; 36(9):7061-7. PubMed ID: 25869879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
    Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
    Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cyclin D1 ubiquitination in UVB-induced murine squamous cell carcinomas.
    Kim AL; Gautier J; Bickers DR; Athar M
    Biochem Biophys Res Commun; 2002 Nov; 298(3):377-82. PubMed ID: 12413951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors.
    Wang J; Wang X; Gong W; Mi B; Liu S; Jiang B
    J Histochem Cytochem; 2009 Apr; 57(4):363-71. PubMed ID: 19064714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.